Paroxetine/Alprazolam

帕罗西汀/阿普唑仑

Report date: 2022/01/14 13:23:58

Base Information

Drug NameParoxetine/Alprazolam
Drug Alias NameParoxetine hydrochloride+Alprazolam阿普唑仑+盐酸帕罗西汀阿普唑仑/盐酸帕罗西汀Alprazolam/ Paroxetine hydrochlorideAlprazolam+Paroxetine hydrochloride +[10] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin transporter inhibitorsGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptorSerotonin transporter
Therapy Area/IndicationsAnxietyDepression
Global Approved IndicationsAnxietyDepression
Approved Indications in ChinaN/A
Original Approved Country/TerritoryMexico
Original Approved Date2012/01/01
Country/TerritoryMexico
CombinationsYes Paroxetine hydrochlorideAlprazolam
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTevaInterlab Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAnxietyDepression
Inactive IndicationsN/A

Other Information

ATC CodeN06CA
Related LinksN/A